Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women

American Journal of Epidemiology

Volumn 153, Issue 11, 2001, Pages 1094-1101

  Barinas Mitchell, Emma ^a   Cushman, Mary ^b   Meilahn, Elaine N ^a   Tracy, Russell P ^b   Kuller, Lewis H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Adipose tissue; Estrone; Hormone replacement therapy; Inflammation; Women

Indexed keywords

C REACTIVE PROTEIN; ESTRONE;

ADULT; ARTICLE; BODY FAT; BODY SIZE; ESTRONE BLOOD LEVEL; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; WEIGHT GAIN;

ADIPOSE TISSUE; ADULT; ALCOHOL DRINKING; ANTHROPOMETRY; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; OBESITY; POSTMENOPAUSE; SMOKING; WEIGHT GAIN;

EID: 0035370489     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/153.11.1094     Document Type: Article

References (38)

1. C-reactive protein as a cardiovascular risk factor more than an epiphenomenon?
2. Nontraditional cardiovascular risk factors
3. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
4. Production of C-reactive protein and risk of coronary events in stable and unstable angina
5. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
6. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
7. Plasma concentrations of C-reactive protein and risk of developing peripheral vascular disease
8. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA Augsburg Cohort Study, 1984 to 1992
9. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
10. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the cardiovascular health study and the rural health promotion projection
11. Evaluating novel cardiovascular risk factors: Can we better predict heart attacks?
12. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
13. Raised C-reactive protein levels from smokers
14. C-reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
15. Effect of post-menopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) study
16. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects
17. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
18. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
19. Hormone replacement therapy, inflammation, and hemostasis in elderly women
20. Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women
21. Menopause and risk factors for coronary heart disease
22. Lipoproteins, estrogens, and the menopause
23. Educational attainment and behavioral and biologic risk factors for coronary heart disease in middle-aged women
24. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
25. Characteristics associated with apoprotein and lipoprotein lipid levels in middle-aged women
26. Hemostatic factors according to menopausal status and use of hormone replacement therapy
27. Relationship of endogenous sex steroid hormones to lipids and apoproteins in post-menopausal women
28. Assessment of adipose tissue distribution by computed axial tomography in obese women: Association with body density and anthropometric measurements
29. Reproducibility of computed tomography measurement of visceral adipose tissue area
30. Anthropometric and psychosocial determinants of visceral obesity in healthy post-menopausal women
31. Body mass index, diabetes, and C-reactive protein among U.S. adults
32. Hormone replacement therapy and increased plasma concentration of C-reactive protein
33. Prior to use of estrogen replacement therapy, are users healthier than nonusers?
34. The adipocyte and hemostatic balance in obesity: Studies of PAI-1
35. Adipogenesis and obesity: Rounding out the big picture
36. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects
37. Elevated C-reactive protein levels in overweight and obese adults
38. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women